Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

China Health Industries Holdings (CHHE)

China Health Industries Holdings (CHHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

China Health Industries Holdings 3199-1 Longxiang Road Songbei District Harbin F4 150028 CHN

www.chinahealthindustries.com P: 86-451-8810-0688

Description:

China Health Industries Holdings Inc. is a manufacturer of health food products through its subsidiaries Harbin Humankind Biology Technology Co., Limited and Heilongjiang Huimeijia Pharmaceutical Co., Ltd. The Company's operating segments consists of Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is involved in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas and oral liquids. China Health Industries Holdings Inc. is based in Harbin City, the Peoples Republic of China.

Key Statistics

Overview:

Market Capitalization, $K 33,425
Enterprise Value, $K 38,525
Shares Outstanding, K 65,540
Annual Sales, $ 110 K
Annual Net Income, $ -410 K
Last Quarter Sales, $ 40 K
Last Quarter Net Income, $ -180 K
EBIT, $ -1,040 K
EBITDA, $ -350 K
60-Month Beta -19.83
% of Insider Shareholders 31.30%
% of Institutional Shareholders 0.00%
Float, K 45,026
% Float 68.70%
Short Volume Ratio 0.85

Growth:

1-Year Return 510.53%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -98.32%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 04/01/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Year -200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CHHE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -5.14%
Return-on-Assets % -4.24%
Profit Margin % -372.73%
Debt/Equity 0.13
Price/Sales 329.75
Price/Cash Flow 132.85
Price/Book N/A
Book Value/Share 0.59
Interest Coverage -0.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar